Results 251 to 260 of about 1,477,269 (300)
COMIC: A Bayesian Dose Optimization Design for Drug Combination in Multiple Indications With Application to CAR-T Therapies. [PDF]
Stat MedChen K, Takeda K, Yuan Y.
europepmc +1 more source
Timely administration of drug combination improves chemoimmunotherapy of an immune-cold tumor. [PDF]
J Control ReleaseMeng F +8 more
europepmc +1 more source
Correction to "A Senomorphlytic Three-Drug Combination Discovered in Salsola collina for Delaying Aging Phenotypes and Extending Healthspan". [PDF]
Adv Sci (Weinh)europepmc +1 more source
DeepSynBa: Actionable Drug Combination Prediction with Complete Dose-Response Profiles
Kuru HI +6 more
europepmc +1 more source
The recent progress of deep-learning-based in silico prediction of drug combination [PDF]
Drug Discovery Today, 2023 Drug combination therapy has become a common strategy for the treatment of complex diseases. There is an urgent need for computational methods to efficiently identify appropriate drug combinations owing to the high cost of experimental screening.
Ting Ran, Yuedong Yang
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of the American Medical Directors Association, 2005
Caring for the elderly nursing home patient has never been more clinically complex or administratively more troublesome. Patients carry with them a greater burden of disease with increasing frailty and vulnerability. More drugs are being used for more problems.
Eric G, Tangalos, Barbara J, Zarowitz
openaire +2 more sources
Caring for the elderly nursing home patient has never been more clinically complex or administratively more troublesome. Patients carry with them a greater burden of disease with increasing frailty and vulnerability. More drugs are being used for more problems.
Eric G, Tangalos, Barbara J, Zarowitz
openaire +2 more sources
Multiple Sclerosis Journal, 1996
As a result of recent therapeutic trials, recombinant Interferon beta (r/FNβ)-1b and-1a as well as Copolymer 1 (COP 1) and to some extent unspecific immunosuppressants have been accepted as partially efficient treatments of relapsing-remitting MS. In view of partially effective single treatments, the question arises if combination of two or even more ...
openaire +3 more sources
As a result of recent therapeutic trials, recombinant Interferon beta (r/FNβ)-1b and-1a as well as Copolymer 1 (COP 1) and to some extent unspecific immunosuppressants have been accepted as partially efficient treatments of relapsing-remitting MS. In view of partially effective single treatments, the question arises if combination of two or even more ...
openaire +3 more sources
2013
Antimicrobial combination therapy has a long history. The potential for synergy between two antimicrobial agents has been sought using in vitro techniques such as disk approximation, checkerboard titration, in vitro killing experiments with fixed drug concentrations, through the use of in vitro pharmacodynamic models, through animal models, and through
openaire +1 more source
Antimicrobial combination therapy has a long history. The potential for synergy between two antimicrobial agents has been sought using in vitro techniques such as disk approximation, checkerboard titration, in vitro killing experiments with fixed drug concentrations, through the use of in vitro pharmacodynamic models, through animal models, and through
openaire +1 more source
Rationale for drug combinations
European Journal of Cancer, 2003No reader of this journal needs to be reminded that real progress in the treatment of solid tumours is hard to achieve. The explosion of scientific knowledge about the metabolism of tumours and the genetic influences that promote or restrict growth will it is hoped lead to the more rationale design of therapeutics, which in future will be more ...
openaire +2 more sources
Combination drug therapy for combined hyperlipidemia
Current Cardiology Reports, 1999Combination therapy for hyperlipidemia, especially combined hyperlipidemia, may have advantages over single drug therapy, affording better improvement in lipoprotein risk factors and possibly better prevention of atherothrombotic events. Although preliminary experience has been gained using treatment combinations of niacin with statins, and fibrates ...
openaire +2 more sources